FORADIL CERTIHALER
LOE ApproachingNDAINHALATIONPOWDER
Approved
Dec 2006
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 17h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
FORADIL CERTIHALER is an inhaled powder formulation approved by the FDA in December 2006 as a small-molecule bronchodilator. The product's specific indication and mechanism of action are not documented in available data, but the inhalation route and powder formulation suggest pulmonary therapeutic use. This is a legacy NDA product from Novartis with a formulation-based (CertIhaler) delivery system.
LOE Approaching
Product is in late-stage life cycle with approaching loss of exclusivity; commercial teams likely focused on defensive positioning and retained market share rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
FORADIL CERTIHALER represents a legacy asset with minimal job-posting activity, indicating a stable but contracting team footprint. Career mobility on this product is limited to defensive and operational roles; significant advancement would require transition to Novartis's growth-stage portfolio.
Brand ManagerField Sales Representative
Worked on FORADIL CERTIHALER at Novartis? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.